Table 1. Clinicopathological parameters of included patient with NPC.

Parameters	Number (%)
Age
<40	20 (45.5%)
≥40	24 (54.5%)
Gender
Male	29 (65.9%)
Female	15 (34.1%)
TNM stage
III	21 (47.7%)
IV	23 (52.3%)
Pathological type
Differentiated	8 (18.2%)
Undifferentiated	36 (81.8%)
Prior treatment
Nasopharynx GTVnx	41.9 ± 25.6
Lymph GTVnx	23.9 ± 38.4
Lymph reduction rate	0.57 ± 0.29
>0.50	26 (59.1%)
≤0.5	18 (40.9%)
Overall reduction rate (%)	0.57 ± 0.23
>0.50	27 (61.4%)
≤0.5	17 (38.6%)